FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.8% | 91.8% | 98.4% | 94.8% | 98.0% | 97.8% | 98.2% | 98.8% | 98.3% | 99.7% | 97.4% | |
| 13.1% | 15.6% | 39.0% | 39.6% | 90.6% | 96.0% | 97.1% | 97.9% | 30.7% | 36.1% | 93.0% | |
| 94.7% | 88.4% | 96.4% | 93.2% | 90.6% | 96.0% | 97.1% | 97.9% | 95.2% | 94.8% | 93.0% | |
| – | – | – | – | – | – | – | – | – | – | 1.0% | |
| 0.7% | 2.1% | 1.3% | 3.9% | 2.0% | 0.2% | – | – | – | – | – | |
| 37.1% | 80.2% | 22.8% | 43.6% | 25.0% | 3.7% | 4.1% | 7.6% | 9.4% | 14.8% | 26.3% | |
| 9.5% | 40.7% | 18.8% | 16.0% | 25.0% | 3.7% | 4.1% | 7.6% | 9.4% | 14.8% | 25.1% | |
| 1.0% | 20.4% | 5.1% | 0.0% | 61.9% | – | – | – | – | – | – | |
| 2.1% | 4.7% | 2.1% | 3.3% | 20.5% | 2.0% | 2.2% | 2.7% | 3.7% | 7.9% | 12.1% | |
| 27.4% | 38.9% | 3.9% | 25.4% | – | – | – | – | – | – | – | |
| 62.9% | 19.8% | 77.2% | 56.4% | 75.0% | 96.3% | 95.9% | 92.4% | 90.6% | 85.2% | 73.7% | |
| -152.0% | -362.1% | -181.3% | -209.4% | -64.9% | -84.0% | -168.9% | -207.3% | -304.1% | -250.2% | -269.8% | |
| 0.1% | 0.1% | 0.0% | 1.3% | 1.1% | 0.5% | 1.3% | 1.7% | 3.2% | 4.7% | 17.8% |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.